Giant primary malignant mesothelioma of the liver: A case report

dc.contributor.authorHaji Ali, Ruba
dc.contributor.authorKhalife, Mohamad Jawad
dc.contributor.authorEl Nounou, Ghina
dc.contributor.authorZuhri Yafi, Ruba
dc.contributor.authorNassar, Hussein
dc.contributor.authorAidibe, Zeinab
dc.contributor.authorRaad, Randa
dc.contributor.authorAbou Eid, Rania
dc.contributor.authorFaraj, Walid G.
dc.contributor.departmentSurgery
dc.contributor.departmentHepatopancreaticobiliary and Liver Transplantation Unit
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.facultyFaculty of Arts and Sciences (FAS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:12:47Z
dc.date.available2025-01-24T12:12:47Z
dc.date.issued2017
dc.description.abstractIntroduction Malignant mesothelioma is a rare neoplasm of mesothelial cells arising most frequently in the pleura or peritoneum and less frequently in the liver. Case presentation We present a case of primary hepatic mesothelioma of 41 year old woman. She had no history of asbestos exposure or cancer. Abdominal computed tomography (CT) showed 21 cm intrahepatic mass in the right lobe with many cystic lesions and few small calcifications. Pathology showed a biphasic cellular pattern. In addition, the tumor cells were positive for Calretinin, Creatine Kinase (CK)5/6, CK7, CKAEI 1/3, Wilms Tumor protein (WT-1), and Vimentin, but were negative for Alpha Feto protein (AFP), Thrombotic Thrombocytopenic Purpura (TTP-1), Anti-Hepatocyte Specific Antigen (HSA), Synaptophysin, CK20, and Homeobox protein (CDx-2). Discussion Primary intrahepatic mesothelioma (PIHMM) is not included in the classification of the World Health Organization classification of hepatic tumors. Mesothelial cells are not normally found in the liver, but some reported cases suggest it may grow from the mesothelial cells of the Glisson's capsule. Conclusion The probability of hepatic mesothelioma should not be ruled out, even in a young woman without a clear history of asbestos exposure. © 2016 The Author(s)
dc.identifier.doihttps://doi.org/10.1016/j.ijscr.2016.11.001
dc.identifier.eid2-s2.0-84998865424
dc.identifier.urihttp://hdl.handle.net/10938/32879
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofInternational Journal of Surgery Case Reports
dc.sourceScopus
dc.subjectCase report
dc.subjectLiver
dc.subjectMalignant mesothelioma
dc.subjectAlpha fetoprotein
dc.subjectAnti hepatocyte specific antigen
dc.subjectAntibody
dc.subjectCalretinin
dc.subjectCreatine kinase
dc.subjectCytokeratin 5
dc.subjectCytokeratin 6
dc.subjectCytokeratin 7
dc.subjectCytokeratin ae1
dc.subjectCytokeratin ae3
dc.subjectProtein
dc.subjectSynaptophysin
dc.subjectThrombotic thrombocytopenic purpura 1 protein
dc.subjectTranscription factor cdx2
dc.subjectUnclassified drug
dc.subjectVimentin
dc.subjectWt1 protein
dc.subjectAdult
dc.subjectArticle
dc.subjectCancer size
dc.subjectCholecystectomy
dc.subjectComputer assisted tomography
dc.subjectDizziness
dc.subjectFatigue
dc.subjectFemale
dc.subjectFever
dc.subjectHepatomegaly
dc.subjectHistopathology
dc.subjectHuman
dc.subjectHuman tissue
dc.subjectLaboratory test
dc.subjectLiver cancer
dc.subjectLiver resection
dc.subjectMesothelioma
dc.subjectPain
dc.subjectPrimary intrahepatic mesothelioma
dc.subjectPriority journal
dc.subjectTachycardia
dc.subjectTumor calcinosis
dc.subjectWeight reduction
dc.titleGiant primary malignant mesothelioma of the liver: A case report
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2017-9194.pdf
Size:
965.96 KB
Format:
Adobe Portable Document Format

Collections